Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Insulin Glargine Vs Standard Insulin Therapy in CFRD Without Fasting Hyperglycemia

NCT00222521 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT00222521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00222521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Insulin Glargine Vs Standard Insulin Therapy in CFRD Without Fasting Hyperglycemia
Lead sponsor
University of Minnesota
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2003
Completion date
August 31, 2005
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis related diabetes